Workflow in scope
One patient or staff journey spanning identity, sensitive data, a consequential update, and confirmation.
48-hour launch review for SMB Healthcare
Patient intake, scheduling, and billing still depend on repetitive manual work across sensitive systems. Get a clear GO / CONDITIONAL GO / NO-GO decision, evidence-ranked findings, and a fix-first plan in 48 hours.
Administrative efficiency without crossing into clinical judgment · $1,000 to $1,500 · 48-hour turnaround
Representative launch decision
healthcare launch readiness
Critical paths
03 exercised
Priority finding
Failure behavior needs a clear user-facing state before launch.
Direct answer
SMB Healthcare · 48-hour Launch Readiness Review
A healthcare app review should prioritise patient identity, record access, appointment and billing integrity, uploaded documents, staff roles, and production configuration. The most important defects often appear in edge cases such as shared devices, expired links, partial saves, and failed integrations.
Workflow in scope
One patient or staff journey spanning identity, sensitive data, a consequential update, and confirmation.
Likely system boundaries
Evidence required
Important boundary
The review finds practical release risks in the agreed surface. It is not a HIPAA audit, penetration test, clinical validation, or regulatory certification.
Read the full 48-hour Launch Readiness Review scopeQuestions, answered
A healthcare app review should prioritise patient identity, record access, appointment and billing integrity, uploaded documents, staff roles, and production configuration. The most important defects often appear in edge cases such as shared devices, expired links, partial saves, and failed integrations.
48-hour Launch Readiness Review is $1,000 to $1,500 with a 48-hour turnaround. The final scope depends on the defined workflow, system access, evidence required, and agreed handover.
Patient information cannot cross accounts or roles Sensitive links, uploads, logs, and errors do not expose data Partial failures cannot silently lose or duplicate appointments and billing actions The engagement should end with an explicit handover and a clear list of remaining risks, not a general claim that the AI is safe.
The review finds practical release risks in the agreed surface. It is not a HIPAA audit, penetration test, clinical validation, or regulatory certification.
Cookie preferences
We use necessary cookies to keep the site running, and optional analytics to see what content helps. No advertising trackers. · Privacy policy